Less Ads, More Data, More Tools Register for FREE

Pin to quick picksESKN.L Regulatory News (ESKN)

  • There is currently no data for ESKN

Trading Statement

2 Feb 2023 07:00

RNS Number : 6587O
Esken Limited
02 February 2023
 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

2 February 2023

ESKEN LIMITED

('Esken' or 'the Group')

 

Esken Renewables Trading Statement

 

Esken, the aviation and renewables group, issues the following update on Esken Renewables' trading performance and management actions.

 

Performance

Biomass plant customers have experienced unplanned outages during the Winter months. These continued and further unforeseen outages in turn have reduced the total volume of waste wood supplied by Esken and the associated gate fee income. Esken Renewables would normally expect to make up these losses over time. However, the proximity to year end has made this unlikely.

 

As a result, Esken Renewables is now expected to deliver EBITDA of £20m for the full year ending 28 February 2023, compared to the previous guidance of £22m as stated at the Interim Results in November 2022. Management anticipate that more normalised plant operating levels will return in FY 2024.

 

Management actions

Esken Renewables has entered into a new sub-supply agreement to support the Chilton Biomass plant which will replace the supply currently provided from the Port Clarence processing and storage site. Esken Renewables will close the Port Clarence site on 31 March 2023 and this action, alongside the new sub-supply agreement, is expected to deliver an additional £0.9m of annual recurring EBITDA from 1 April 2023. The closure of the Port Clarence site will also generate a one off cash inflow of £0.9m after exit costs.

 

The new sub supply arrangement does not impact the Chilton Biomass Fuel Supply Agreement with Esken Renewables, which runs to December 2029.

 

Enquiries:

Esken Limited C/o Tulchan Communications

Charlie Geller, Group Communications DirectorTulchan Communications

Olivia Peters / Lisa Jarrett-Kerr

020 7353 4200

esken@tulchangroup.com 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTTBMLTMTAMBIJ
Date   Source Headline
21st Dec 20224:35 pmRNSPrice Monitoring Extension
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
15th Dec 20224:35 pmRNSPrice Monitoring Extension
8th Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn
1st Dec 20224:36 pmRNSPrice Monitoring Extension
29th Nov 20221:49 pmRNSResult of EGM
24th Nov 20224:35 pmRNSPrice Monitoring Extension
10th Nov 20227:00 amRNSTR-1
9th Nov 20227:00 amRNSInterim Results
9th Nov 20227:00 amRNSNotice of EGM
3rd Nov 20227:00 amRNSNotice of Results
19th Oct 202210:18 amRNSTR-1
12th Sep 20224:41 pmRNSSecond Price Monitoring Extn
12th Sep 20224:35 pmRNSPrice Monitoring Extension
12th Sep 202210:53 amRNSListing Rule 9.6.14(2) Disclosure
31st Aug 20227:00 amRNSTrading Statement
22nd Aug 20224:35 pmRNSPrice Monitoring Extension
10th Aug 20224:35 pmRNSPrice Monitoring Extension
5th Aug 202210:59 amRNSTR-1
28th Jul 20224:35 pmRNSPrice Monitoring Extension
13th Jul 20222:43 pmRNSAGM results
5th Jul 20224:35 pmRNSPrice Monitoring Extension
5th Jul 20227:00 amRNSDirector/PDMR Shareholding
30th Jun 20227:00 amRNSAudit tender outcome and annual general meeting
23rd Jun 20224:35 pmRNSPrice Monitoring Extension
17th Jun 20224:41 pmRNSSecond Price Monitoring Extn
17th Jun 20224:37 pmRNSPrice Monitoring Extension
16th Jun 20222:27 pmRNSDirector/PDMR Shareholding
13th Jun 20224:36 pmRNSPrice Monitoring Extension
13th Jun 20223:28 pmRNSPosting of Annual Report and Notice of AGM
10th Jun 20224:36 pmRNSPrice Monitoring Extension
8th Jun 20224:35 pmRNSPrice Monitoring Extension
1st Jun 20224:36 pmRNSPrice Monitoring Extension
27th May 20224:40 pmRNSSecond Price Monitoring Extn
27th May 20224:35 pmRNSPrice Monitoring Extension
25th May 20227:00 amRNSFinal Results
18th May 20221:03 pmRNSDirector/PDMR Shareholding
18th May 20227:00 amRNSNotice of Results
12th May 20224:42 pmRNSSecond Price Monitoring Extn
12th May 20224:36 pmRNSPrice Monitoring Extension
30th Mar 20224:35 pmRNSPrice Monitoring Extension
22nd Mar 20227:00 amRNSTrading Statement
11th Mar 20224:35 pmRNSPrice Monitoring Extension
4th Mar 20224:42 pmRNSSecond Price Monitoring Extn
4th Mar 20224:36 pmRNSPrice Monitoring Extension
23rd Feb 20227:00 amRNSAppointment of Joint Broker
18th Feb 20224:40 pmRNSSecond Price Monitoring Extn
18th Feb 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.